Cutando A, Montero J, Gómez-de Diego R, Ferrera MJ,
Lopez-Valverde A. Effect of topical
application of melatonin on serum levels of C-reactive protein (CRP),
interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in patients
with type 1 or type 2 diabetes and periodontal disease. J Clin Exp Dent. 2015;7(5):e628-33.
doi:10.4317/jced.52604
References
1. Ridgeway EE.
Periodontal disease: diagnosis and management. J Am Acad
Nurse Pract. 2000;12:79-84. |
|
|
|
2. Loesche
WJ. Bacterial mediators in periodontal disease. Clin
Infect Dis. 1993;16:S203-10. |
|
|
|
3. Lalla
E, Cheng B, Lal S, Tucker S, Greenberg E, Goland R, et al. Periodontal changes in children and
adolescents with diabetes: a case-control study. Diabetes Care. 2006;29:295-9. |
|
|
|
4. Loos
BG, Craandijk J, Hoek FJ,
Wertheim-van Dillen PM, van der
Velden U. Elevation of systemic markers related to
cardiovascular diseases in the peripheral blood of periodontitis
patients. J
Periodontol. 2000;71:1528-34. |
|
|
|
5.
El Fadl KA, Ragy N, El Batran M, Kassem N, Nasry SA, Khalifa R, et al. Periodontitis and cardiovascular disease: Floss and reduce a potential risk factor
for CVD. Angiology. 2011;62:
62-7. |
|
|
|
6. Dissick
A, Redman RS, Jones M, Rangan BV, Reimold A, Griffiths GR, et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J
Periodontol. 2010;81:223-30. |
|
|
|
7. Chun YH, Chun KR, Olguin D, Wang HL. Biological foundation for periodontitis as a potential risk factor for
atherosclerosis. J
Periodontal Res. 2005;40:87-95. |
|
|
|
8.
Kobayashi T, Murasawa A, Komatsu Y, Yokoyama T, Ishida K, Abe A, et al. Serum cytokine and periodontal profiles in relation to disease
activity of rheumatoid arthritis in Japanese adults. J Periodontol. 2010;81:650-7. |
|
|
|
9.
Yamazaki K, Honda T, Oda T, Ueki-Maruyama
K, Nakajima T, Yoshie H,
et al. Effect of periodontal treatment on the C-reactive protein
and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal
Res. 2005;40:53-8. |
|
|
|
10.
Duarte PM, da Rocha M, Sampaio E, Mestnik MJ, Feres M, Figueiredo LC, et al. Serum levels of cytokines in subjects with generalized chronic and
aggressive periodontitis before and after
non-surgical periodontal therapy. J Periodontol.
2010;81:1056-63. |
|
|
|
11. Westfelt
E, Rylander H, Blohmé G, Jonasson P, Lindhe J. The
effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol. 1996;23:92-100. |
|
|
|
12. Sun WL, Chen LL, Zhang
SZ, Ren YZ, Qin GM. Changes of adiponectin
and inflammatory cytokines after periodontal intervention in type 2 diabetes
patients with periodontitis. Arch Oral Biol. 2010;55:970-4. |
|
|
|
13. Marigo
L, Cerreto R, Giuliani M, Somma
F, Lajolo C, Cordaro M.
Diabetes mellitus: biochemical, histological and microbiological aspects in
periodontal disease. Eur Rev Med Pharmacol
Sci. 2011;15:751-8. |
|
|
|
14.
Correa FO, Gonzalves D, Figueredo CM, Bastos AS, Gustafsson A, Orrico SR. Effect of periodontal treatment on metabolic
control, systemic inflammation and cytokines in patients with type 2
diabetes. J Clin Periodontol.
2010;37:53-8. |
|
|
|
15.
Mayer Y, Balbir-Gurman A, Machtei
EE. Anti-tumor necrosis factor-alpha therapy and
periodontal parameters in patients with rheumatoid arthritis. J Periodontol. 2009;80:1414-20. |
|
|
|
16.
Kammoun HL, Kraakman MJ, Febbraio MA. Adipose
tissue inflammation in glucose metabolism. Rev Endocr
Metab Disord. 2014;15:31-44. |
|
|
|
17. Grover HS, Luthra S. Molecular mechanisms involved in the
bidirectional relationship between diabetes mellitus and periodontal disease.
J
Indian Soc Periodontol. 2013;17:292-301. |
|
|
|
18. Cutando
A, López-Valverde A, Gómez-de-Diego
R, Arias-Santiago S, de Vicente-Jiménez J. Effect
of gingival application of melatonin on alkaline and acid phosphatase,
osteopontin and osteocalcin
in patients with diabetes and periodontal disease. Med Oral Patol Oral Cir Bucal. 2013;18:e657-63. |
|
|
|
19. Reiter RJ,
Rosales-Corral SA, Liu XY, Acuna-Castroviejo D, Escames G, Tan DX.Melatonin in
the oral cavity: physiological and pathological implications. J Periodontal Res. 2015;50:9-17. |
|
|
|
20.
Cutando A, Galindo P, Gómez-Moreno G, Arana C,
Bolaños J, Acuña-Castroviejo D, et al. Relationship between salivary melatonin and severity
of periodontal disease. J Periodontol. 2006;77:1533-38. |
|
|
|
21.
Cutando A, Aneiros-Fernández
J, López-Valverde A, Arias-Santiago S, Aneiros-Cachaza
J, Reiter RJ. A new perspective in Oral health: potential importance and actions of
melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity. Arch Oral
Biol. 2011;56:944-50. |
|
|
|
22. Fain JN. Release of
interleukins and other inflammatory cytokines by human adipose tissue is
enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006;74:443-77. PMid:17027526 |
|
|
|
23. Kardesler
L, Buduleni N, Cetinkal
SD. Adipokines and inflammatory mediators after
initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis. J Periodontol.
2010;81:24-33. |
|
|
|
24. Ide
M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase
inflammatory and vascular responses. J Clin Periodontol. 2003;30:334-40. |
|
|
|
25. Paraskevas
S, Huizinga JD, Loos BG. A systematic review and
meta-analyses on C-reactive protein in relation to periodontitis.
J
Clin Periodontol. 2008;35:277-90. |
|
|
|
26.
Freitas CO, Gomes-Filho IS, Naves RC, Nogueira Filho Gda R, Cruz SS, Santos
CA, et al. Influence of periodontal therapy on C-reactive
protein level: a systematic review and meta-analysis. J Appl
Oral Sci. 2012;20:1-8. |
|
|
|
27. Almughrabi
OM, Marzouk KM, Hasanato
RM, Shafik SS. Melatonin levels in periodontal
health and disease. J Periodont Res. 2013;48:315-21. |
|
|
|
28. Dag A, Firat ET, Arikan S, Kadiroğlu AK, Kaplan A. The effect of periodontal
therapy on serum TNF-alpha and HbA1c levels in type 2 diabetic patients. Aust Dent J. 2009;54:17-22. |
|
|
|
29. Nakajima T, Honda T, Domon H, Okui T, Kajita K, Ito H, et al. Periodontitis-associated
up-regulation of systemic inflammatory mediator level may increase the risk
of coronary heart disease. J Periodont Res. 2010;45:116-22. |
|
|
|
30. Aspiras
MB, Barros SP, Moss KL, Barrow DA, Phillips ST, Mendoza L, et al. Clinical
and subclinical effects of power brushing following experimental induction of
biofilm overgrowth in subjects representing a
spectrum of periodontal disease. J Clin Periodontol. 2013;40:1118-25. |